Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share - Schedule of Comparison of Basic and Fully Diluted Net Loss Per Share (Details)

v3.21.1
Loss Per Share - Schedule of Comparison of Basic and Fully Diluted Net Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Earnings Per Share [Abstract]    
Net loss - before noncontrolling interest $ (10,110) $ (14,911)
Net loss attributable to noncontrolling interest 679 436
Net loss - as reported, attributable to PAVmed Inc. (9,431) (14,475)
Series B Convertible Preferred Stock dividends - earned [1] (75) (70)
Net loss attributable to PAVmed Inc. common stockholders $ (9,506) $ (14,545)
Weighted average common shares outstanding, basic and diluted [2] 73,954,126 43,499,714
Basic and diluted - Net loss - as reported, attributable to PAVmed Inc. $ (0.13) $ (0.33)
Basic and diluted - Net loss attributable to PAVmed Inc. common stockholders $ (0.13) $ (0.33)
[1] The Series B Convertible Preferred Stock dividends earned as of the each of the respective periods noted, are included in the calculation of basic and diluted net loss attributable to PAVmed Inc. common stockholders for each respective period presented. Notwithstanding, the Series B Convertible Preferred Stock dividends are recognized as a dividend payable only upon the dividend being declared payable by the Company's board of directors.
[2] Basic weighted-average number of shares of common stock outstanding for the three months ended March 31, 2021 and 2020 include the shares of the Company issued and outstanding during such periods, each on a weighted average basis. The basic weighted average number of shares outstanding excludes common stock equivalent incremental shares, while diluted weighted average number of shares outstanding includes such incremental shares. However, as the Company was in a loss position for all periods presented, basic and diluted weighted average shares outstanding are the same, as the inclusion of the incremental shares would be anti-dilutive.